Perspective
Sotorasib: First Approved <i>KRAS</i> Mutation Inhibitor for the Treatment of Non-small Cell Lung Cancer
[ Vol.
30 , Issue.
9 ]
Author(s):
Surya K. De*
Pages
1000 -
1002 (
3 )
Abstract:
Keywords:
KRAS G12C mutation, sotorasib, rat sarcoma viral oncogene (RAS), lung cancer, mechanism of action, pharmacokinetics.
Affiliation:
Read Full-Text article